Pharmaceutical Executive March 6, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics, dives into the greatest threats to the integrity of data in R&D and threats presented by hackers.

In a world rife with optimism about the good that AI can do, what threat is presented to pharma by bad actors, like hackers, but for their own nefarious purposes?

AI brings a lot of potential benefits, AI accelerates a lot of thinking, it can contemplate a lot of data, it can, it can help us, you know, filter out things. And I’m not going to go into the cautions of AI in the drug discovery process. But I’ll talk about the way AI. The way we use AI or...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Big Data, Biotechnology, Cybersecurity, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe?
Community Pharmacists as Experts on Complex Patient Encounters
On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval
The First Diagnostic Immunome

Share This Article